Strategies for the prevention of atherosclerotic progression in women

Cardiology in Review

Volumn 10, Issue 2, 2002, Pages 119-125

  Rackley, Charles E ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Atheroslerotic; Management; Risk factors

Indexed keywords

ANTILIPEMIC AGENT; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE REGULATION; DIABETES MELLITUS; DISEASE COURSE; HORMONE SUBSTITUTION; HYPERCHOLESTEROLEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; LIFESTYLE; MENOPAUSE; PATHOGENESIS; RISK FACTOR; SMOKING; SMOKING CESSATION; SYSTOLIC BLOOD PRESSURE;

EID: 0036126986     PISSN: 10615377     EISSN: None     Source Type: Journal    
DOI: 10.1097/00045415-200203000-00010     Document Type: Article

References (39)

1. Atherosclerosis: An inflammatory disease
2. Revalence and extent of atherosclerosis in adolescents and young adults
3. Fatty streak formation occurs in human fetal aorta and is greatly enhanced by maternal hypercholesterolemia: Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions
4. Risk factors that attenuate the female coronary artery disease advantage
5. Cardiovascular basis for cholesterol therapy
6. Menopause and risk of cardiovascular disease: The Framingham study
7. Low density lipoprotein oxidation and its pathobiological significance
8. Involvement of oxidation: Sensitive mechanisms in the cardiovascular effects of hypercholesterolemia
9. Estrogen and inhibition of low density lipoprotein in post menopausal women
10. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women
11. Hormone replacement therapy and increased plasma concentration of C-reactive protein
12. Association of C-reactive protein with measures of obesity, insulin resistance and subclinical atherosclerosis in healthy, middle age women
13. Lessons from animal models
14. Methylation of the estrogen receptor gene is associated with aging and atherosclerosis in the cardiovascular system
15. Guide to preventive cardiology for women: Lipid changes after hormonal loss in females: AHA/ACC Scientific Statement Consensus Panel statement
16. Total cholesterol to high density lipoprotein cholesterol ratio is best predictor of angiographic coronary artery disease in women
17. Risk factors for cardiovascular disease in women
18. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
19. Chronic subclinical inflammation as part of the insulin resistance syndrome: The Insulin Resistance Atherosclerosis Study (IRAS)
20. Energy restriction and weight loss on very low-fat diets reduced C-reactive protein concentrations in obese, healthy women
21. Coronary artery disease in women: Risk factors, evaluation, treatment and prevention
22. Prediction of coronary heart disease using risk factor categories
23. Natural history of coronary artery disease in women
24. Angiotensin II induces LOX-I, the human endothelial receptor for oxidized low density lipoprotein
25. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol level: Results of AFCAPS/TEXCAPS
26. The Postmenopausal Estrogen/Progestin Intervention (PEPI) trial
27. Effects of hormone replacement therapy on serum lipids in elderly women
28. Design of the Women's Health Initiative Clinical Trial and Observational study
29. Regression of atherosclerosis in atherosclerotic monkeys
30. Paradigm shift in coronary artery disease
31. Randomized trial of cholesterol lowering in 4,444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S) trial
32. Effects of pravastatin on cardiovascular events in women after myocardial infarction: The Cholesterol and Recurrent Events (CARE) trial
33. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
34. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
35. Effects of estrogen replacement on progression of coronary artery atherosclerosis
36. Beyond the null hypothesis: Do the HERS results disprove the estrogen/coronary heart disease hypothesis?
37. Estrogen and progestin, lipoprotein (a) and the risk of recurrent coronary heart/ disease events after menopause
38. Post menopausal hormone use and secondary prevention of coronary events in the Nurses Health study